Thomas Andrea B 4
Research Summary
AI-generated summary
Medifast (MED) Director Thomas Andrea B Receives RSU Award
What Happened
- Thomas Andrea B, a director of Medifast, Inc. (MED), was granted 11,680 restricted stock units (RSUs) on 2026-05-26. The units were granted at $0.00 (no cash paid) and represent the right to one share each when vested. The filing was submitted on 2026-05-28.
Key Details
- Transaction type: Award/Grant (Form 4 code A)
- Date of grant/reporting: 2026-05-26 (Period of Report); Form 4 filed 2026-05-28
- Shares/units granted: 11,680 RSUs; grant price reported as $0.00 (value realized on vesting)
- Vesting: RSUs vest in full on May 26, 2027
- Plan(s): Granted under the Medifast Director's Deferred Compensation Plan and issued from the Amended and Restated 2012 Share Incentive Plan (see footnote)
- Shares owned after transaction: Not specified in the filing
- Timeliness: Filing appears timely (filed two days after the grant)
Context
- RSU grants to directors are a common form of non-cash compensation and do not represent an open-market purchase or sale. Each unit converts to one share upon vesting, so the economic value is realized only if/when the units vest and shares are delivered. This award is a routine director compensation item rather than an immediate market trade.